by in
Entry Author Date Location
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Targeted Genetics Seeks Merger 11/12/10 Seattle
Ceregene Adds $11.5M 11/11/10 San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition 10/01/10 Boston
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder 09/15/10 Boston
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out 08/18/10 Seattle
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio 07/08/10 San Francisco
Ceregene Gets $2.5M From Fox Foundation 06/23/10 San Diego
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
Celladon Enjoys Early Success With Gene Therapy Trial, FDA Gives Digirad Green Light for a Nuclear Camera, Aragon Pharmaceuticals Gets $22M & More San Diego Biotech News 04/29/10 San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News 03/17/10 Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News 03/11/10 San Diego
Tocagen, Developing Anti-Cancer Therapies, Close to Closing on $8M Round 03/08/10 San Diego
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Targeted Genetics Exits Nasdaq 01/13/10 Seattle
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M 12/23/09 Boston
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice 10/14/09 San Diego
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round 09/15/09 San Diego
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News 09/10/09 San Diego
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News 09/10/09 Seattle
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M 09/09/09 National
Page 3 of 4 « previous page · next page »